Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.40 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.40 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7948095 | 1.00 | NT5E (0.54) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7955939 | 0.90 | NT5E (0.56) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7955938 | 0.90 | NT5E (0.56) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7948100 | 0.89 | NT5E (0.55) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7955504 | 0.89 | NT5E (0.55) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7955508 | 0.89 | NT5E (0.55) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7948307 | 0.88 | NT5E (0.64) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7948306 | 0.88 | NT5E (0.64) | NT5EBCHESSTR1SSTR2SSTR4 | |
| SCHEMBL7948148 | 0.88 | NT5E (0.53) | NT5ELGALS8SLC6A2 | |
| SCHEMBL7948144 | 0.88 | NT5E (0.53) | NT5ELGALS8SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0819135-B1 | SUGAR-MODIFIED CYTOSTATICS | BAYER AG (DE) | 1999-11-17 | — | — | EP | disclosed |